Boehringer Ingelheim (Canada) Ltd. and Eli Lilly Canada Inc. announced today the Government of?Quebec?will continue to provide public funding of?JARDIANCE??(empagliflozin),?SYNJARDY??(a single-pill combination of empagliflozin and metformin), and?TRAJENTA